• Dose- and Time-Dependent Neurotoxicity of Ibotenic Acid in M

  2026-07-02

  This study provides the first systematic in vivo analysis of ibotenic acid toxicity in mice, revealing clear dose- and time-dependent neurotoxic effects. The findings identify early behavioral, biochemical, and neuronal alterations, offering new markers for mechanistic research and clinical intervention in neurotoxic mushroom poisoning.

• Vasopressin Analogues: Expanding Therapeutic Horizons in Pep

  2026-07-01

  This review synthesizes current knowledge on vasopressin and its analogues, highlighting how structural modifications yield compounds like lypressin acetate with distinct pharmacological profiles. The reference study explores their established roles in fluid homeostasis, vasoconstriction, and emerging antiviral applications, providing technical insights for translational and assay-driven research.

• PAD4-IN-2 TFA: Mechanistic Innovation in Tumor-Targeted NET

  2026-07-01

  PAD4-IN-2 TFA (Compound 5i TFA) exemplifies a new generation of tumor-targeted PAD4 inhibitors, leveraging meta-phenylboronic acid (m-PBA) modification for selective uptake by sialic acid-rich tumor cells. This article dissects the mechanistic basis, experimental validation, and translational promise of PAD4-IN-2 TFA, highlighting its unique ability to inhibit the PAD4–H3cit–NETs axis, suppress tumor metastasis, and modulate the immune microenvironment. Going beyond conventional product summaries, we synthesize recent peer-reviewed evidence with strategic guidance for researchers aiming to optimize translational workflows, and position PAD4-IN-2 TFA as a versatile, safety-validated tool for next-generation cancer research.

• Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Canc

  2026-06-30

  Ferrostatin-1 (Fer-1) transforms the reliability of ferroptosis assays, enabling precise inhibition of oxidative lipid damage in complex disease models. Learn how to elevate your experimental workflow, troubleshoot common pitfalls, and interpret breakthrough findings from recent translational oncology research.

• Resazurin Sodium Salt in Precision Viability Assays: Mechani

  2026-06-30

  This article explores the mechanistic underpinnings and translational impact of Resazurin sodium salt as a fluorogenic oxidation-reduction indicator. Drawing from recent advances in disease modeling and high-throughput screening, we highlight best practices, contextualize APExBIO’s offering within a competitive landscape, and outline strategic guidance for translational researchers pursuing robust, clinically relevant cell viability and cytotoxicity readouts.

• Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi

  2026-06-29

  Methyl-β-cyclodextrin (SKU C6939) addresses the need for targeted, reproducible extraction of cholesterol and select lipids from cellular membranes, supporting studies of membrane fluidity, lipid raft organization, and cholesterol-dependent signaling. This reagent is suitable for biochemical and cell-based research workflows but is not intended for diagnostic or clinical applications.

• Lanabecestat (AZD3293): Optimizing BACE1 Inhibition in Alzhe

  2026-06-29

  Lanabecestat (AZD3293) stands out as a nanomolar, blood-brain barrier-penetrant BACE1 inhibitor that enables precise modulation of amyloid-beta production in Alzheimer's disease research. This guide offers actionable workflow strategies, data-driven protocol parameters, and troubleshooting insights to maximize experimental reproducibility and safety.

• ORAI2/JNK/NFAT1 Axis Drives Early Salivary Gland Fibrosis Po

  2026-06-28

  This study uncovers a pivotal role for ORAI2-mediated store-operated calcium entry in driving early-stage postirradiation fibrosis of salivary glands. By dissecting the ORAI2/JNK/NFAT1 signaling axis, researchers demonstrate that targeted SOCE inhibition alleviates fibrosis and restores gland function, offering a mechanistic rationale for innovative fibrosis therapies.

• SMYD2 Inhibition with AZ505 Mitigates Renal Fibrosis and Inf

  2026-06-27

  This study demonstrates that pharmacological inhibition of SMYD2, specifically using AZ505, protects against cisplatin-induced renal fibrosis and inflammation in a chronic kidney disease (CKD) model. The findings highlight SMYD2 as a pivotal regulator of renal fibrosis, with substrate-competitive inhibition showing therapeutic promise for renal and potentially broader epigenetic regulation research.

• Optimizing Calcium Signaling with 2,5-di-tert-butylbenzene-1

  2026-06-26

  This comprehensive guide explores how 2,5-di-tert-butylbenzene-1,4-diol (BHQ, SKU B6648) enables rigorous, reproducible calcium signaling research and HSC mobilization. Grounded in peer-reviewed studies and real-world lab workflows, it demonstrates the practical advantages of BHQ for biomedical scientists.

• YTHDF1 Phase Separation Orchestrates SSC Fate via IkB-NF-kB-

  2026-06-26

  Fang et al. demonstrate that liquid-liquid phase separation (LLPS) of YTHDF1, an m6A reader, is pivotal for the direct transdifferentiation of spermatogonial stem cells (SSCs) into neural stem cell-like cells. By selectively repressing IkBa/b mRNA translation, YTHDF1 LLPS activates the IkB-NF-kB-CCND1 axis, revealing a crucial mechanism for cell fate transition and offering new insights for regenerative and translational research.

• Phalloidin (B7678): Protocol Guidance for F-Actin Stabilizat

  2026-06-25

  Phalloidin (B7678) is a cyclic heptapeptide toxin optimized for high-affinity stabilization and visualization of filamentous actin (F-actin) in fixed and permeabilized samples. This reagent addresses the need for robust, species-independent cytoskeleton analysis in microscopy workflows but is not suitable for live-cell imaging or studies requiring reversible actin interactions.

• 3X (DYKDDDDK) Peptide: Precision in Protein Tagging & Purifi

  2026-06-25

  The 3X (DYKDDDDK) Peptide elevates recombinant protein workflows through unmatched affinity purification and immunodetection sensitivity. Its triple-repeat design, robust metal-ion compatibility, and minimal impact on protein function make it the tag of choice for advanced molecular and structural biology experiments.

• EGTA in Translational Neurocardiac Research: Mechanisms & St

  2026-06-24

  This thought-leadership article explores the selective chelation properties of EGTA (egtzic acid) in the context of cardiac vagal neuron signaling and neuroprotection. Building on recent mechanistic insights from voltage-dependent calcium channel research, it offers translational researchers actionable guidance for leveraging EGTA in advanced calcium signaling assays, including protocol parameters, workflow considerations, and a forward-looking view on its role in neurodegenerative and cardiovascular models. By drawing together evidence from foundational studies and emerging industry perspectives, this article positions APExBIO’s EGTA as a premier tool for next-generation mechanistic investigations beyond the typical scope of product resources.

• Strategic Targeting of MCL-1: Translational Impact of A-1210

  2026-06-23

  This thought-leadership article explores the mechanistic underpinnings and translational potential of selectively targeting MCL-1 in cancer with the potent inhibitor A-1210477. Integrating new evidence from breast cancer models, it offers strategic guidance for researchers aiming to optimize mitochondrial apoptosis assays and position their work at the frontier of precision oncology.

455 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page